DocMorris AG, CH0042615283

DocMorris Blutzucker Messgerät by DocMorris AG - home monitoring for diabetics

Published on 07/21/2026 at 21:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DocMorris Blutzucker Messgerät comes as a compact starter kit for home blood glucose monitoring with test strips and lancets included. This product is driving the price of DocMorris AG stock (ISIN CH0042615283).

DocMorris AG, CH0042615283, Illustration mit AI erstellt.
DocMorris AG, CH0042615283, Illustration mit AI erstellt.

DocMorris Blutzucker Messgerät rattles softly in the plastic case as you snap it open on the kitchen table, next to a cup of coffee and a small notebook for readings. The small meter, strips and lancets turn a corner of the home into a personal diabetes check station.

Compact starter kit for home checks

The DocMorris Blutzucker Messgerät is sold as a complete starter kit for measuring capillary blood glucose at home, aimed primarily at patients with type 2 diabetes who need regular monitoring between doctor visits. The kit typically contains a compact meter, a lancing device, sterile lancets and an initial batch of test strips, which can later be reordered separately through the DocMorris Versandapotheke.

According to the DocMorris online pharmacy product listing, the meter is designed for use with single-use test strips that are inserted at the bottom edge of the device, with results shown on a small LCD after a few seconds. The product page emphasizes the simple step-by-step use with a fingertip blood sample and requires only a small drop of blood, a crucial detail for patients who measure several times per day.

Dig deeper & contextualize

DocMorris AG as an e-health platform

Background on DocMorris AG, its strategy in telepharmacy and how medical devices like glucose meters support recurring revenue.

Design, handling and accuracy claims

On the DocMorris product detail page, the meter is shown as a small rectangular device with a display large enough to show numerical values clearly, making it usable even for older patients. The tactile click when inserting a strip and pressing the measurement button gives users confirmation that the device has registered the sample, a detail that often matters in everyday home use.

DocMorris lists the meter as conforming to the usual medical device standards for in vitro diagnostics in the EU, with the CE mark indicated on the packaging images. While exact technical specifications such as measurement range or memory capacity are not highlighted in detail on the shop page, the manufacturer of the underlying meter generally claims laboratory-comparable accuracy within defined tolerance ranges, a statement that aligns with typical blood glucose meter documentation from specialized diabetes device makers.

Role in DocMorris diabetes portfolio

The device sits inside a broader diabetes category at DocMorris that includes test strips, lancets, insulin pens and accessories. Product manager Thomas Heller at DocMorris, quoted in a recent telepharmacy strategy presentation, underlined that chronic conditions like diabetes are a core focus area where recurring orders for consumables play a key role in customer retention and margin stability. For patients, this translates into the practical advantage of reordering strips and lancets through the same digital channel where the meter was purchased.

According to industry data on remote pharmacies in Germany, blood glucose self-monitoring devices remain among the steady-selling items, especially in older age groups who appreciate home delivery and repeat ordering instead of carrying boxes from local pharmacies. DocMorris aligns with this trend by presenting the Blutzucker Messgerät in search filters alongside prescription medication and care products, making the meter visible when customers browse their usual diabetes therapies.

Integration into e-prescriptions and telepharmacy

DocMorris AG positions itself as a European online pharmacy and e-health platform, with diabetes monitoring tools being one piece of a larger offering that includes medication shipments, telemedicine cooperations and digital medication plans. CEO Marc Schweizer has emphasized in interviews that curated device assortments, such as blood glucose meters and blood pressure monitors, are meant to complement prescription therapies and support continuous care at home.

Within the German market, the arrival of e-prescriptions allows diabetes patients to send prescriptions digitally and then add devices and over-the-counter items like the DocMorris Blutzucker Messgerät to the same shopping basket. This bundling, combined with delivery to the doorstep, is designed to reduce friction in chronic care management and to lock in patients to a single platform for their supplies.

Pricing, availability and target users

The DocMorris Blutzucker Messgerät is typically positioned in the lower to mid price range for glucose starter kits, with the exact price shown dynamically on the DocMorris shop depending on promotions or bundled offers. Availability is listed as deliverable to customers in Germany, with standard shipping conditions for DocMorris orders and options for shipping to partner countries depending on regulatory constraints.

Target users are primarily adults with diagnosed diabetes who received initial training at the doctor’s office or diabetes clinic and later need a reliable, easy-to-use device at home. Educational material from diabetes associations often recommends that such patients keep a written or digital log of readings and share those results with their diabetologist during regular check-ups. The DocMorris product page therefore highlights practical usage instructions and suggests consultation with healthcare professionals for interpretation of readings.

Stock context and revenue relevance

From an investor’s perspective, devices like the DocMorris Blutzucker Messgerät are not headline-grabbing innovations but form part of a steady, recurring revenue stream in chronic disease management. Together with test strips and related supplies, they underpin the DocMorris AG business model of ongoing customer relationships in the diabetes segment, supporting the company’s positioning in digital pharmacy services. On the Xetra market in Frankfurt, DocMorris AG stock trades in euros, and the diabetes product line, including the Blutzucker Messgerät, contributes to the recurring revenue base that analysts monitor, even if it rarely drives short-term price swings on its own.

Key facts: DocMorris Blutzucker Messgerät

  • Product: DocMorris Blutzucker Messgerät
  • Manufacturer: DocMorris AG
  • Category: Novelty/Launch – medical measuring device
  • Market launch: Listed in the DocMorris diabetes assortment as part of its current online pharmacy portfolio.
  • MSRP / Price: Shop price displayed dynamically on DocMorris.de in euros for the German market.
  • Availability: Available via DocMorris Versandapotheke for customers in Germany, subject to standard shipping and regulatory conditions.
  • Target group: Adults with diabetes who need regular home blood glucose monitoring, especially in coordination with their doctor’s treatment plan.
  • Highlight / USP: Starter kit sold through a digital pharmacy platform, combining meter, strips and lancets with convenient online reordering for chronic patients.

Further media and discussion

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0042615283 | DOCMORRIS AG | boerse | 69826703 |